CAMBRIDGE, England—Diabetes healthcare company Novo Nordisk has entered into a multiyear agreement to use the I2E semantic knowledge discovery platform of Linguamatics Ltd., a provider of enterprise text mining for the life science and other markets, for text mining, the companies announced last month. Novo Nordisk said I2E will be used to mine published literature and internal information sources “to provide business-critical intelligence for R&D decision makers.” Financial details of the agreement were not disclosed.